<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04740502</url>
  </required_header>
  <id_info>
    <org_study_id>PHP-DISC</org_study_id>
    <nct_id>NCT04740502</nct_id>
  </id_info>
  <brief_title>Surgical Outcomes in Patients With Primary Hyperparathyroidism and Unclear Preoperative Localisation Studies</brief_title>
  <official_title>Surgical Approach and Outcomes in Patients With Primary Hyperparathyroidism and Unclear Preoperative Localisation Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cagliari</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cagliari</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although some surgeons still consider bilateral neck exploration as the best approach for&#xD;
      primary hyperparathyroidism, nowadays most of them perceive the mini-invasive&#xD;
      parathyroidectomy (MIP) as the best option for patients with concordant preoperative studies.&#xD;
      Nevertheless, the consensus is heterogeneous for patients with unclear localisation studies,&#xD;
      with some surgeons deeming BNE as mandatory and others suggesting that a mini-invasive&#xD;
      approach is still possible if combined with IOPTH monitoring. In our research, we focused on&#xD;
      patients with unclear preoperative localisation studies, to better understand the factors&#xD;
      that can determine discordant or negative results between US and MIBI scan, in order to&#xD;
      choose the best surgical approach and to evaluate the outcomes in this kind of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an unicentric, retrospective study on patients who underwent surgery for PHP from&#xD;
      January 2004 to June 2020 at our Department of General and Endocrine surgery, which is a&#xD;
      tertiary referral centre for parathyroid disease. Ethical approval was released from our&#xD;
      Local Independent Ethical Committee. Patients involved in the study subjects gave informed&#xD;
      consent to the work.&#xD;
&#xD;
      In our study, we included only patients who underwent both US and MIBI preoperatively. The&#xD;
      exclusion criteria were the association of total or partial thyroidectomy planned&#xD;
      preoperatively for thyroid disease, reoperative surgery for persistent or recurrent PHP, and&#xD;
      incomplete data or follow-up.&#xD;
&#xD;
      The primary aims of this study were:&#xD;
&#xD;
        -  To identify predictive factors of unclear preoperative localisation studies.&#xD;
&#xD;
        -  To evaluate if a mini-invasive approach is feasible in this kind of patients,&#xD;
           considering the incidence of persistent PHP as the main outcome.&#xD;
&#xD;
      The secondary outcomes were:&#xD;
&#xD;
        -  To assess the role of IOPTH assay in patients with unclear localisation studies.&#xD;
&#xD;
        -  To evaluate the accuracy of preoperative localisation studies in our series,&#xD;
           particularly in patients with discordant or negative US and MIBI scan.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2008</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical failure</measure>
    <time_frame>6 months</time_frame>
    <description>Incidence of persistent hyperparathyroidism</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">242</enrollment>
  <condition>Primary Hyperparathyroidism</condition>
  <arm_group>
    <arm_group_label>Concordant preoperative studies</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with concordant neck ultrasound and MIBI scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unclear preoperative studies</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with discordant or negative neck ultrasound and MIBI scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Parahtyroidectomy</intervention_name>
    <description>Parathyroidectomy</description>
    <arm_group_label>Concordant preoperative studies</arm_group_label>
    <arm_group_label>Unclear preoperative studies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with primary hyperparathyroidism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with concomitant thyroid disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Policlinico di Monserrato</name>
      <address>
        <city>Monserrato</city>
        <state>Cagliari</state>
        <zip>09040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico di Monserrato</name>
      <address>
        <city>Monserrato</city>
        <state>CA</state>
        <zip>09042</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cagliari</investigator_affiliation>
    <investigator_full_name>Fabio Medas</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Hyperparathyroidism, Primary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

